Express Scripts Announces 2017 Fourth Quarter and Full Year Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Express Scripts (ESRX) PT Raised to $88 at Cowen; Positioned for Growth
February 28, 2018 1:59 PM ESTCowen raised its price target on Express Scripts (NASDAQ: ESRX) to $88.00 (from $80.00) while maintaining an Outperform rating.
Analyst Charles Rhyee commented, "ESRX reported adj. EPS ahead of expectations w/ core EBITDA up 5% y/y, due to better than expected GM, likely as a... More
Express Scripts (ESRX) PT Raised to $83 at Evercore ISI; Call 'Reassuring'
February 28, 2018 12:46 PM ESTEvercore ISI raised its price target on Express Scripts (NASDAQ: ESRX) to $83.00 (from $81.00) while maintaining an In Line rating.
Analyst Ross Muken liked that the company is expecting retention rate for the 2018 selling season between 96% - 98% above last years. In addition,... More
Express Scripts (ESRX) Tops Q4 EPS by 7c, Offers Guidance
February 27, 2018 4:02 PM EST(Updated - February 27, 2018 4:03 PM EST)
Express Scripts (NASDAQ: ESRX) reported Q4 EPS of $2.16, $0.07 better than the analyst estimate of $2.09. Revenue for the quarter came in at $25.38 billion versus the consensus estimate of $25.11 billion.
Business Outlook
"With a significant number of our largest renewals completed and strong momentum in the market, we are in a position to provide an early look at our consolidated retention rate for the 2018 selling season, which we expect to... More
